======= MARCH5 ======= == Gene Information == * **Official Symbol**: MARCHF5 * **Official Name**: membrane associated ring-CH-type finger 5 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=54708|54708]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q9NX47|Q9NX47]] * **Interactions**: [[https://thebiogrid.org/search.php?search=MARCH5&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20MARCH5|Open PubMed]] * **OMIM**: [[https://omim.org/entry/610637|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Mitochondrial E3 ubiquitin-protein ligase that plays a crucial role in the control of mitochondrial morphology by acting as a positive regulator of mitochondrial fission. May play a role in the prevention of cell senescence acting as a regulator of mitochondrial quality control. Promotes ubiquitination of FIS1, DNM1L and MFN1. {ECO:0000269|PubMed:16874301, ECO:0000269|PubMed:17606867, ECO:0000269|PubMed:19741096, ECO:0000269|PubMed:20103533}. |RINGv| |positive regulation of mitochondrial fission| |regulation of mitochondrial fission| |negative regulation of cell aging| |GTPase binding| |regulation of cell aging| |protein autoubiquitination| |protein localization to mitochondrion| |positive regulation of mitochondrion organization| |mitochondrial outer membrane| |regulation of mitochondrion organization| |ubiquitin-protein transferase activity| |protein polyubiquitination| |positive regulation of organelle organization| |protein ubiquitination| |protein localization to organelle| |protein modification by small protein conjugation| |zinc ion binding| |endoplasmic reticulum membrane| |negative regulation of developmental process| |protein modification by small protein conjugation or removal| |endoplasmic reticulum| |regulation of anatomical structure morphogenesis| |positive regulation of cellular component organization| |mitochondrion| |regulation of organelle organization| |positive regulation of developmental process| |cellular protein localization| |cellular macromolecule localization| |membrane| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp226|Cerivastatin 0.15μM R05 exp226]]|-1.88| |[[:results:exp48|Mubritinib 0.2μM R01 exp48]]|1.71| |[[:results:exp41|BI-2536 0.001μM R01 exp41]]|1.72| |[[:results:exp7|Bortezomib 0.05μM R00 exp7]]|1.72| |[[:results:exp275|Citral 75μM R06 exp275]]|1.73| |[[:results:exp534|Trientine 500μM R08 exp534]]|1.73| |[[:results:exp17|DABN 20μM R00 exp17]]|1.76| |[[:results:exp5|Alpha-Amanitin 0.5μM R00 exp5]]|1.81| |[[:results:exp448|Ammonium tetrathiomolybdate 10μM R08 exp448]]|1.81| |[[:results:exp515|PU-H71 1μM R08 exp515]]|1.82| |[[:results:exp529|Thimerosal 0.85μM R08 exp529]]|1.82| |[[:results:exp350|Deferoxamine 11μM R07 exp350]]|1.86| |[[:results:exp73|LJH685 5μM R02 exp73]]|1.86| |[[:results:exp198|Etoposide 0.1μM R05 exp198]]|1.87| |[[:results:exp175|3-Bromopyruvate 7μM R04 exp175]]|1.9| |[[:results:exp507|Monensin 0.3μM R08 exp507]]|1.95| |[[:results:exp525|Sulforaphane 9μM R08 exp525]]|1.97| |[[:results:exp81|Selumetinib 20μM R02 exp81]]|2.05| |[[:results:exp214|2-Deoxy-D-glucose 800μM R05 exp214]]|2.16| |[[:results:exp416|Tubacin 1.6μM R07 exp416]]|2.16| |[[:results:exp330|5-Azacytidine 2μM R07 exp330]]|2.19| |[[:results:exp259|6-Thio-2-deoxyguanosine 2μM R06 exp259]]|2.28| |[[:results:exp455|Benzoate 10000μM R08 exp455]]|2.29| |[[:results:exp356|Docosahexaenoic-acid 50μM R07 exp356]]|2.29| |[[:results:exp374|Latrunculin-B 10μM R07 exp374]]|2.3| |[[:results:exp210|LB-100 2μM R05 exp210]]|2.31| |[[:results:exp240|Pyridostatin 4μM R05 exp240]]|2.32| |[[:results:exp216|Erlotinib 10μM R05 exp216]]|2.33| |[[:results:exp355|Dinaciclib 0.007μM R07 exp355]]|2.36| |[[:results:exp439|QNZ 0.01μM R08 exp439]]|2.36| |[[:results:exp505|ML-792 0.2μM R08 exp505]]|2.43| |[[:results:exp532|TIC10 10μM R08 exp532]]|2.51| |[[:results:exp6|Bortezomib 0.005μM R00 exp6]]|2.53| |[[:results:exp343|Centrinone 0.5μM R07 exp343]]|2.57| |[[:results:exp472|CI-1040 9.5μM R08 exp472]]|2.57| |[[:results:exp441|GSK-J4 1.5μM R08 exp441]]|2.59| |[[:results:exp531|THZ1 0.06μM R08 exp531]]|2.6| |[[:results:exp407|Thapsigargin 0.005μM R07 exp407]]|2.62| |[[:results:exp38|Wortmannin 5μM R00 exp38]]|2.65| |[[:results:exp450|Artemisinin 50μM R08 exp450]]|2.68| |[[:results:exp414|Tozasertib 0.1μM R07 exp414]]|2.73| |[[:results:exp459|Bleomycin 5μM R08 exp459]]|2.74| |[[:results:exp72|LB-100 4.1μM R02 exp72]]|2.77| |[[:results:exp134|MS023 2μM R03 exp134]]|2.85| |[[:results:exp503|Mitomycin-C 0.06μM R08 exp503]]|3.1| |[[:results:exp436|Dynasore 7μM R08 exp436]]|3.29| |[[:results:exp34|Rotenone 20μM R00 exp34]]|3.29| |[[:results:exp435|JQ1 0.8μM R08 exp435]]|3.33| |[[:results:exp440|Aphidicolin 0.4μM R08 exp440]]|3.39| |[[:results:exp357|Dorsomorphin 5μM R07 exp357]]|3.39| |[[:results:exp180|Dynasore 10μM R04 exp180]]|3.42| |[[:results:exp211|AICAR 240μM R05 exp211]]|3.44| |[[:results:exp451|Atovaquone 15μM R08 exp451]]|3.46| |[[:results:exp443|SNS-032 15μM R08 exp443]]|3.63| |[[:results:exp527|Tanespimycin 14μM R08 exp527]]|3.67| |[[:results:exp199|Etoposide 0.3μM R05 exp199]]|3.88| |[[:results:exp84|UM0125461 0.74μM R02 exp84]]|3.89| |[[:results:exp488|Hippuristanol 0.12μM R08 exp488]]|3.96| |[[:results:exp19|Etoposide 1μM R00 exp19]]|4.02| |[[:results:exp489|Hippuristanol 0.12μM R08 exp489 no dilution day6]]|4.07| |[[:results:exp517|Quercetin 20μM R08 exp517]]|4.09| |[[:results:exp80|RO-3307 4.7μM R02 exp80]]|4.34| |[[:results:exp474|CR131-b 0.005μM R08 exp474]]|4.36| |[[:results:exp478|Doxorubicin 0.02μM R08 exp478]]|4.57| |[[:results:exp116|AICAR 240μM R03 exp116]]|4.71| |[[:results:exp85|UM0129480 7μM R02 exp85]]|4.97| |[[:results:exp485|GSK626616 14μM R08 exp485]]|5.05| |[[:results:exp524|Staurosporine 0.02μM R08 exp524]]|5.12| |[[:results:exp512|Olaparib 4μM R08 exp512]]|5.41| |[[:results:exp234|Ethanol 0.01 R05 exp234]]|5.56| |[[:results:exp135|MS023 7μM R03 exp135]]|6.52| |[[:results:exp28|Pimelic-diphenylamide-106 5μM R00 exp28]]|6.96| |[[:results:exp2|5-Fluorouracil 20μM R00 exp2]]|6.98| |[[:results:exp456|Benzoate 20000μM R08 exp456]]|7.88| |[[:results:exp3|Actinomycin-D 0.001μM R00 exp3]]|7.94| ^Gene^Correlation^ |[[:human genes:b:bak1|BAK1]]|0.846| |[[:human genes:v:vdac2|VDAC2]]|0.802| |[[:human genes:u:ubqln1|UBQLN1]]|0.755| |[[:human genes:c:casp9|CASP9]]|0.751| |[[:human genes:a:apaf1|APAF1]]|0.744| |[[:human genes:c:cycs|CYCS]]|0.707| |[[:human genes:p:plaa|PLAA]]|0.688| |[[:human genes:h:hccs|HCCS]]|0.67| |[[:human genes:s:serf2|SERF2]]|0.663| |[[:human genes:d:diablo|DIABLO]]|0.646| |[[:human genes:f:faf2|FAF2]]|0.592| |[[:human genes:s:stau1|STAU1]]|0.585| |[[:human genes:a:atad1|ATAD1]]|0.559| |[[:human genes:m:mfn1|MFN1]]|0.558| |[[:human genes:d:dohh|DOHH]]|0.557| |[[:human genes:h:hspd1|HSPD1]]|0.522| |[[:human genes:e:eny2|ENY2]]|0.513| |[[:human genes:f:fech|FECH]]|0.496| |[[:human genes:h:hars|HARS]]|0.492| |[[:human genes:g:gabpa|GABPA]]|0.485| |[[:human genes:r:romo1|ROMO1]]|0.473| |[[:human genes:m:metap2|METAP2]]|0.467| |[[:human genes:m:mlst8|MLST8]]|0.465| |[[:human genes:r:rptor|RPTOR]]|0.464| |[[:human genes:p:pmaip1|PMAIP1]]|0.458| |[[:human genes:t:triap1|TRIAP1]]|0.457| |[[:human genes:m:mtor|MTOR]]|0.457| |[[:human genes:u:uap1|UAP1]]|0.45| |[[:human genes:t:thg1l|THG1L]]|0.448| |[[:human genes:b:bap1|BAP1]]|0.448| |[[:human genes:d:ddhd2|DDHD2]]|0.446| |[[:human genes:g:gfpt1|GFPT1]]|0.443| |[[:human genes:b:bcl2l11|BCL2L11]]|0.441| |[[:human genes:z:zzz3|ZZZ3]]|0.438| |[[:human genes:k:kctd5|KCTD5]]|0.436| |[[:human genes:s:srrd|SRRD]]|0.43| |[[:human genes:w:wdr24|WDR24]]|0.428| |[[:human genes:a:alas1|ALAS1]]|0.428| |[[:human genes:n:nsd1|NSD1]]|0.427| |[[:human genes:m:mcl1|MCL1]]|0.424| |[[:human genes:l:lamtor5|LAMTOR5]]|0.424| |[[:human genes:r:rad23b|RAD23B]]|0.421| |[[:human genes:p:pdpk1|PDPK1]]|0.421| |[[:human genes:k:kdsr|KDSR]]|0.421| |[[:human genes:m:meaf6|MEAF6]]|0.421| |[[:human genes:v:vhl|VHL]]|0.42| |[[:human genes:n:nxt1|NXT1]]|0.417| |[[:human genes:c:csnk2b|CSNK2B]]|0.413| |[[:human genes:g:gmppb|GMPPB]]|0.412| |[[:human genes:n:nae1|NAE1]]|0.41| |[[:human genes:u:uba3|UBA3]]|0.407| |[[:human genes:w:wdr59|WDR59]]|0.407| |[[:human genes:f:fbxo11|FBXO11]]|0.407| |[[:human genes:m:mios|MIOS]]|0.406| |[[:human genes:o:opa1|OPA1]]|0.403| |[[:human genes:a:atp5j|ATP5J]]|0.402| Global Fraction of Cell Lines Where Essential: 63/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|2/28| |blood|12/28| |bone|3/26| |breast|6/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|4/20| |lung|3/75| |lymphocyte|3/16| |ovary|1/26| |pancreas|0/24| |peripheral nervous system|1/16| |plasma cell|9/15| |prostate|1/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|1/22| |urinary tract|2/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 15886 * **Expression level (log2 read counts)**: 5.26 {{:chemogenomics:nalm6 dist.png?nolink |}}